BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16870281)

  • 1. A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does Clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention?
    Moore RK; Lowe R; Grayson AD; Morris JL; Perry RA; Stables RH
    Int J Cardiol; 2007 Mar; 116(1):93-7. PubMed ID: 16870281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Byrne RA; Ndrepepa G; Braun S; Tiroch K; Mehilli J; Schulz S; Schömig A; Kastrati A
    Am J Cardiol; 2010 Nov; 106(9):1212-7. PubMed ID: 21029815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty.
    Ohnishi N; Iwasaki K; Kusachi S; Hirami R; Matano S; Ohnishi H; Takeda K; Kita T; Sakakibara N; Tsuji T
    Jpn Heart J; 1998 Mar; 39(2):139-46. PubMed ID: 9687822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of high-dose aspirin pre-treatment on the incidence of myonecrosis following elective coronary stenting.
    Gulec S; Ozdol C; Vurgun K; Selcuk T; Turhan S; Duzen V; Temizhan A; Ozturk S; Ozdemir AO; Erol C
    Atherosclerosis; 2008 Mar; 197(1):171-6. PubMed ID: 17434171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
    Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
    J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
    Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E
    J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
    Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting.
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Coron Artery Dis; 1996 Jul; 7(7):535-40. PubMed ID: 8913672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.
    Kruse JM; Enghard P; Schröder T; Hasper D; Kühnle Y; Jörres A; Storm C
    Int J Cardiol; 2014 May; 173(2):216-21. PubMed ID: 24636545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention.
    Herrmann J; Lennon RJ; Jaffe AS; Holmes DR; Rihal CS; Prasad A
    Circ Cardiovasc Interv; 2014 Aug; 7(4):533-42. PubMed ID: 25052010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention.
    Cai Q; Skelding KA; Armstrong AT; Desai D; Wood GC; Blankenship JC
    Am J Cardiol; 2007 Mar; 99(5):616-20. PubMed ID: 17317359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.